Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)
China flag China · Delayed Price · Currency is CNY
22.69
+0.99 (4.56%)
At close: Mar 10, 2026

SHE:002393 Revenue

In the year 2025, Tianjin Lisheng Pharmaceutical had annual revenue of 1.39B CNY with 4.23% growth. Tianjin Lisheng Pharmaceutical had revenue of 385.38M in the quarter ending December 31, 2025, with 23.37% growth.

Revenue
1.39B
Revenue Growth
+4.23%
P/S Ratio
4.17
Revenue / Employee
868.24K
Employees
1,604
Market Cap
5.81B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.39B56.51M4.23%
Dec 31, 20241.34B183.12M15.88%
Dec 31, 20231.15B6.44M0.56%
Jan 1, 20231.15B54.65M5.00%
Jan 1, 20221.09B-48.90M-4.29%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Jan 1, 2018 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition